NCT01406522View on ClinicalTrials.gov

Tacrine Effects on Cocaine Self-Administration and Pharmacokinetics

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

October 31, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

November 30, 2013

Conditions
Cocaine Dependence
Interventions
DRUG

Oral tacrine

Tacrine, 160 mg per day, four times daily

DRUG

Oral placebo

Microcrystalline cellulose

Trial Locations (1)

64128

Kansas City VA Medical Center, Kansas City

Sponsors
All Listed Sponsors
lead

Midwest Biomedical Research Foundation

OTHER

NCT01406522 - Tacrine Effects on Cocaine Self-Administration and Pharmacokinetics | Biotech Hunter | Biotech Hunter